| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |